The short answer
Yes: take vitamin E at least 4 hours before colesevelam. That is the label's instruction for anyone on oral vitamin supplements, because colesevelam may reduce absorption of the fat-soluble vitamins A, D, E and K, and the label gives the interval as before, not after, the colesevelam dose. Extra vitamin E is not routinely needed: in the adolescent trial the label relies on, fat-soluble vitamin levels did not differ from placebo, and adult trial reviews found no clinically significant vitamin changes. If you take warfarin, keep vitamin E doses moderate, since large doses can add to bleeding risk.
What this answer covers
Vitamin E (alpha-tocopherol, natural or synthetic) supplements and multivitamins taken with colesevelam hydrochloride tablets or oral suspension.
- Supplement or preparation
- vitamin E
- Medication ingredient
- colesevelam
What the label says
The WELCHOL label states that colesevelam may decrease absorption of fat-soluble vitamins A, D, E and K, that people with malabsorption syndromes or other susceptibility are at increased risk, and that patients on oral vitamin supplementation should take their vitamins at least 4 hours prior to colesevelam. It also reports no significant effects on fat-soluble vitamin levels or clotting factors relative to placebo in the adolescent study.
Why 4 hours before
Colesevelam is a polymer that stays in the gut and binds what is there with it. In healthy volunteers, drugs such as glyburide and levothyroxine lost exposure when swallowed with colesevelam, but taking them 4 hours before colesevelam removed the interaction; the study authors concluded a 4-hour window is sufficient. The label applies the same window to oral vitamins and does not give an interval for taking them after colesevelam. For example, vitamins with breakfast and colesevelam with a later meal can work if there is at least a 4-hour gap before every colesevelam dose and the timing fits your prescribed schedule.
Is extra vitamin E needed
The pediatric study enrolled 194 children aged 10 to 17. It compared colesevelam with placebo for 8 weeks, followed by an 18-week open-label phase in which all participants received colesevelam. The label reports no significant effects on fat-soluble vitamin levels or clotting factors relative to placebo; this was not a 26-week placebo comparison. A review of the early adult trials reported no clinically significant vitamin changes. These findings do not establish a routine need for extra vitamin E. Long-term effects remain uncertain, particularly in people with fat-malabsorption disorders, whose need for testing or supplementation should be assessed individually.
Dose caution
Vitamin E in large doses, probably above 400 IU daily, can antagonize vitamin K-dependent clotting factors and increase bleeding risk with anticoagulants. The colesevelam label separately flags people on warfarin as susceptible to vitamin K deficiency. If you take warfarin, discuss vitamin E supplements and any dose changes with the clinician managing your anticoagulation. The adult upper intake level for supplemental vitamin E is 1,000 mg daily, but this does not establish a safe dose with warfarin. Report unusual bruising or bleeding.
Evidence and practical considerations
Timing & monitoring
Take oral vitamin E at least 4 hours before colesevelam, as the label directs for oral vitamin supplements; the 4-hours-before window eliminated interactions for tested drugs, and no interval after colesevelam is labeled.
- Exact scope
- Alpha-tocopherol supplements at any dose; adult upper limit 1,000 mg daily. with Colesevelam hydrochloride tablets and powder for oral suspension (WELCHOL and generics), 3.75 g daily; the polymer is not absorbed, so any effect happens in the gut.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- The label instruction is class-wide for vitamins; the interval evidence comes from prescription drugs, not vitamin E.
Factors that may matter: Time between doses; Vitamin E dose; Warfarin or other anticoagulants.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 22, 2026
Population: People prescribed colesevelam
WELCHOL may decrease absorption of fat-soluble vitamins A, D, E and K; patients with malabsorption syndromes or otherwise susceptible to fat-soluble vitamin deficiency may be at increased risk. Patients on oral vitamin supplementation should take their vitamins at least 4 hours prior to WELCHOL. In the adolescent study there were no significant effects on fat-soluble vitamin levels or clotting factors relative to placebo.
How this applies: Exact colesevelam hydrochloride (RxCUI 141626) tablets and oral suspension; the vitamin instruction covers oral vitamin supplements as a group.
No vitamin E-specific measurement, dose or after-dose interval is given.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 22, 2026
Population: Healthy adult volunteers in six open-label randomized studies.
Concomitant colesevelam lowered exposure to glyburide, levothyroxine and ethinyl estradiol and the peak of repaglinide and norethindrone; when the drug was taken 4 hours before colesevelam no interaction was observed, and the authors concluded a 4-hour window appears sufficient.
How this applies: Explains the label's 4-hours-before rule and the direction (before, not after); it is not vitamin-specific.
Tested prescription drugs, not vitamins; single doses in healthy volunteers.
Source 3: clinical review
pmc.ncbi.nlm.nih.gov · Source check Sep 22, 2026
Population: Children and adolescents with heterozygous familial hypercholesterolemia.
Colesevelam may decrease absorption of some medications such as multivitamins and should be given at least four hours after them; absorption of fat-soluble vitamins may be decreased; the authors call for further trials on long-term complications such as fat-soluble vitamin depletion. They suggest giving colesevelam with dinner, or split between lunch and dinner, when vitamins are taken at breakfast.
How this applies: Full-text review confirming the label's timing direction and the absence of long-term vitamin data.
Review, not original data; its four-hour advice restates the label.
Source 4: federal nutrient fact sheet
ods.od.nih.gov · Source check Sep 22, 2026
Population: General population; no colesevelam co-use data
Alpha-tocopherol is the form that meets human needs; frank deficiency is rare but people with fat-malabsorption disorders are more likely to become deficient. The Tolerable Upper Intake Level is 1,000 mg daily for adults. Vitamin E can inhibit platelet aggregation and antagonize vitamin K-dependent clotting factors, so large doses, probably above 400 IU daily, raise bleeding risk with anticoagulants, especially when vitamin K intake is low.
How this applies: Defines the supplement, its upper limit, the malabsorption risk group and a vitamin K interaction relevant to people also warned about vitamin K on colesevelam.
General nutrient guidance; the bleeding statement concerns anticoagulants, not colesevelam.
Research assessment: · Open full citations ↗
Absorption & effectiveness
Colesevelam is labeled as possibly decreasing vitamin E absorption, but the controlled adolescent study behind the label found no significant effect on fat-soluble vitamin levels versus placebo and adult trial reviews report no clinically significant vitamin changes; malabsorption remains the risk group.
- Exact scope
- Alpha-tocopherol supplements. with Colesevelam hydrochloride tablets and powder for oral suspension (WELCHOL and generics), 3.75 g daily; the polymer is not absorbed, so any effect happens in the gut.
- Medication form and route
- oral medication; oral supplement
What remains uncertain
- Vitamin results are read from the label and reviews rather than primary abstracts; 6 to 26 weeks; no data with supplements or in malabsorption.
Factors that may matter: Underlying malabsorption; Duration of colesevelam use.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 22, 2026
Population: People prescribed colesevelam
WELCHOL may decrease absorption of fat-soluble vitamins A, D, E and K; patients with malabsorption syndromes or otherwise susceptible to fat-soluble vitamin deficiency may be at increased risk. Patients on oral vitamin supplementation should take their vitamins at least 4 hours prior to WELCHOL. In the adolescent study there were no significant effects on fat-soluble vitamin levels or clotting factors relative to placebo.
How this applies: Exact colesevelam hydrochloride (RxCUI 141626) tablets and oral suspension; the vitamin instruction covers oral vitamin supplements as a group.
No vitamin E-specific measurement, dose or after-dose interval is given.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 22, 2026
Population: One hundred and ninety-four children aged 10 to 17 years, 129 treated with colesevelam.
LDL-cholesterol fell 12.5 percent with 3.75 g daily versus placebo; the abstract reports lipid results and that adverse events were evaluated, but gives no vitamin values. The WELCHOL label (section 8.4) draws on this population for its statement that fat-soluble vitamin levels and clotting factors showed no significant effects relative to placebo.
How this applies: The controlled study behind the label's null fat-soluble vitamin statement; adolescents without malabsorption.
Vitamin outcomes are not in the abstract; the null vitamin statement is read from the label, not the paper; 26 weeks total.
Source 3: review of clinical trials
pubmed.ncbi.nlm.nih.gov · Source check Sep 22, 2026
Population: Adults with primary hypercholesterolemia in the early trials.
In humans colesevelam did not induce clinically significant changes in serum levels of vitamins, coagulation parameters or liver enzymes; it did not alter the pharmacokinetics of several co-administered drugs.
How this applies: Summarizes the adult trial vitamin data that the primary abstracts omit; medication-only exposure.
Narrative review read as an abstract; underlying vitamin data are not shown; trials lasted 6 to 24 weeks.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Editorial update | |
| Source-checked release edit clarified study design, exact evidence scope and practical wording. This research edit does not constitute clinical approval. | |
| Research summary published | |
| Article prepared | |
| Prepared exact colesevelam and Vitamin E article from inspected current labeling and original sources, with uncertainty stated. |
Article revision: a802c4e47334e361
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.